Manfred Wälti

447 total citations
29 papers, 318 citations indexed

About

Manfred Wälti is a scholar working on Pharmacology, Social Psychology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Manfred Wälti has authored 29 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 8 papers in Social Psychology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Manfred Wälti's work include Neuroendocrine regulation and behavior (8 papers), Drug-Induced Adverse Reactions (7 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Manfred Wälti is often cited by papers focused on Neuroendocrine regulation and behavior (8 papers), Drug-Induced Adverse Reactions (7 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Manfred Wälti collaborates with scholars based in Switzerland, United Kingdom and United States. Manfred Wälti's co-authors include D. B. Hope, K Neftel, J Gubler, Beda M. Stadler, Alain L. de Weck, Chein Soo Hong, A.L. de Weck, Donald J. Winzor, Sigmund A. Weitzman and H Bürgi and has published in prestigious journals such as The Lancet, Gastroenterology and Biochemical Journal.

In The Last Decade

Manfred Wälti

29 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manfred Wälti Switzerland 12 106 55 54 42 39 29 318
Peter Ward United Kingdom 13 57 0.5× 20 0.4× 212 3.9× 46 1.1× 44 1.1× 32 516
Nobuhiko Nakazawa Japan 10 30 0.3× 29 0.5× 169 3.1× 29 0.7× 31 0.8× 16 361
Manik Ganguly United States 12 16 0.2× 76 1.4× 150 2.8× 41 1.0× 54 1.4× 16 456
Urs R. Joss Switzerland 11 26 0.2× 75 1.4× 189 3.5× 16 0.4× 47 1.2× 21 514
Joseph Byron United Kingdom 10 25 0.2× 34 0.6× 159 2.9× 90 2.1× 119 3.1× 17 534
R.J. Warren United Kingdom 9 14 0.1× 45 0.8× 161 3.0× 37 0.9× 36 0.9× 14 362
Susanne L. Griffiths United Kingdom 14 55 0.5× 46 0.8× 461 8.5× 82 2.0× 39 1.0× 20 605
M. Jones Tunisia 12 44 0.4× 40 0.7× 104 1.9× 118 2.8× 33 0.8× 72 517
A. Teíchmann Germany 14 19 0.2× 71 1.3× 144 2.7× 14 0.3× 131 3.4× 43 608
D. A. Long Tanzania 14 42 0.4× 18 0.3× 85 1.6× 33 0.8× 75 1.9× 41 445

Countries citing papers authored by Manfred Wälti

Since Specialization
Citations

This map shows the geographic impact of Manfred Wälti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manfred Wälti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manfred Wälti more than expected).

Fields of papers citing papers by Manfred Wälti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manfred Wälti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manfred Wälti. The network helps show where Manfred Wälti may publish in the future.

Co-authorship network of co-authors of Manfred Wälti

This figure shows the co-authorship network connecting the top 25 collaborators of Manfred Wälti. A scholar is included among the top collaborators of Manfred Wälti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manfred Wälti. Manfred Wälti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wüthrich, B., et al.. (1987). [Acetylsalicylic acid and pyrazole allergy or pseudo-allergy?].. PubMed. 62(6). 470–8. 1 indexed citations
2.
Wüthrich, B., et al.. (1986). «Soforttyp»-Reaktionen auf Pyrazol-Derivate: Ergebnisse von Hauttesten und Antikörperbestimmungen. Dermatology. 173(1). 24–28. 3 indexed citations
3.
Dewdney, Janet M., et al.. (1986). Measurement of Specific IgG Antibody Levels in Serum of Patients on Regimes Comprising High Total Dose Beta-Lactam Therapy. International Archives of Allergy and Immunology. 79(4). 344–348. 7 indexed citations
4.
Wälti, Manfred, et al.. (1986). [Radioimmunologic detection of IgE and IgG antibodies against drugs. Conclusions after experience with over 1200 patients].. PubMed. 116(10). 303–5. 2 indexed citations
5.
Hong, Chein Soo, Beda M. Stadler, Manfred Wälti, & Alain L. de Weck. (1986). Dot-immunobinding assay with monoclonal anti-IgE antibodies for the detection and quantitation of human IgE. Journal of Immunological Methods. 95(2). 195–202. 35 indexed citations
6.
Wälti, Manfred, et al.. (1986). [IE and IgG antibodies against flavonoids following therapy with flavonoid-containing drugs].. PubMed. 116(4). 98–103. 6 indexed citations
7.
Gmür, J, Manfred Wälti, & K Neftel. (1985). Amoxicillin-Induced Immune Hemolysis. Acta Haematologica. 74(4). 230–233. 12 indexed citations
8.
Wälti, Manfred, et al.. (1983). [Demonstration of drug-specific IgE and IgG antibodies using RIA: clinical importance as shown with nomifensin (Alival)].. PubMed. 113(49). 1865–7. 3 indexed citations
9.
Jaeger, Albert, et al.. (1983). [Immunoallergic intravascular hemolysis and tubulointerstitial nephritis due to penicillin G].. PubMed. 12(30). 1859–62. 1 indexed citations
10.
Müller, Martin, et al.. (1983). [Semisynthetic penicillins and cephalosporins inhibit in vitro myelopoiesis in a dose-dependent manner].. PubMed. 113(40). 1471–3. 1 indexed citations
11.
Kristensen, F., Christoph Walker, Manfred Wälti, & A.L. de Weck. (1982). Development of a Serum‐Free Defined Culture Medium for Lymphoblast Transformation Tests of Mouse Spleen and Thymus Cells. Scandinavian Journal of Immunology. 16(3). 209–216. 13 indexed citations
12.
Wälti, Manfred, et al.. (1982). EFFECT OF STORAGE OF PENICILLIN-G SOLUTIONS ON SENSITISATION TO PENICILLIN-G AFTER INTRAVENOUS ADMINISTRATION. The Lancet. 319(8279). 986–988. 40 indexed citations
13.
Wälti, Manfred, et al.. (1981). Neutropenia after penicillins: Toxic or immune-mediated?. Journal of Molecular Medicine. 59(16). 877–888. 32 indexed citations
14.
Schneider, Conrad H., et al.. (1979). Monovalent elicitation of passive cutaneous anaphylaxis by N1-DNCP-N6-BPO-diaminohexane. Molecular Immunology. 16(4). 269–279. 11 indexed citations
15.
Bisset, G. W., et al.. (1979). HYDROXY ANALOGUES OF OXYTOCIN AND OF LYSINE‐VASOPRESSIN. British Journal of Pharmacology. 67(4). 575–585. 2 indexed citations
16.
Hope, D. B. & Manfred Wälti. (1974). Proton-Beam Therapy of Pituitary Disease. Proceedings of the Royal Society of Medicine. 67(1). 40–42. 2 indexed citations
17.
Wälti, Manfred & Derek B. Hope. (1974). Synthesis of [1-(D-2-hydroxy-3-mercaptopropanoic acid)]oxytocin, a diastereoisomer of the hydroxy-isostere of oxytocin. Journal of the Chemical Society Perkin Transactions 1. 2(0). 202–205. 2 indexed citations
18.
Hope, Derek B. & Manfred Wälti. (1973). [2-(3-Nitrotyrosine)]oxytocin, a weakly active analogue of the hormone bound by neurophysin (Short Communication). Biochemical Journal. 135(1). 241–243. 4 indexed citations
19.
Hope, D. B. & Manfred Wälti. (1971). [1-(L-2-Hydroxy-3-mercaptopropanoic acid)]-oxytocin, a highly potent analogue of oytocin not bound by neurophysin. Biochemical Journal. 125(3). 909–911. 14 indexed citations
20.
Hope, D. B., Christopher D. Morgan, & Manfred Wälti. (1970). Reduction of benzyl sulphonyl (sulphone) intermediates to sulphinic acids. Synthesis of hypotaurine, and ofL-cysteine andL-homocysteine sulphinic acids. Journal of the Chemical Society C Organic. 0(2). 270–273. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Ward Breakdown of academic impact, for papers by Nobuhiko Nakazawa Breakdown of academic impact, for papers by Manik Ganguly Breakdown of academic impact, for papers by Urs R. Joss Breakdown of academic impact, for papers by Joseph Byron Breakdown of academic impact, for papers by R.J. Warren Breakdown of academic impact, for papers by Susanne L. Griffiths Breakdown of academic impact, for papers by M. Jones Breakdown of academic impact, for papers by A. Teíchmann Breakdown of academic impact, for papers by D. A. Long
Rankless by CCL
2026